Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As Rousseff Impeachment Looms Could Her Successor Help Pharma In Brazil?

Executive Summary

Brazil is not an easy place to do business at the moment. Its economy is in deep recession, its political class is mired in a far-reaching corruption scandal and now it looks increasingly likely that President Dilma Rousseff will be impeached for fiddling the figures to make the fiscal deficit look better. "But from the very bottom, the only place to go is up," says Benny Spiewak, from the Brazilian law firm Zancaner Costa, Bastos and Spiewak. He thinks a new leader could do much for pharmaceutical R&D and restore relations with an embattled industry.

You may also be interested in...



Brazil, Mexico Taking Divergent Paths On Regulatory Reform

Anvisa is in the process of trying to reduce some of its red tape, but the excessive bureaucracy at COFEPRIS is likely to remain in place for the foreseeable future.

Brazilian Notebook: Key Themes From BIO Latin America

Population size and favorable biosimilar policies highlight the opportunities for biotech in Brazil, but economic turmoil and other factors pose challenges.

Brazilian Notebook: Key Themes From BIO Latin America

Population size and favorable biosimilar policies highlight the opportunities for biotech in Brazil, but economic turmoil and other factors pose challenges.

Topics

UsernamePublicRestriction

Register

GB150366

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel